Citations (124)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Vittorio Emanuele Bianchi, Pomares Fredy Herrera & Rizzi Laura. (2021) Effect of nutrition on neurodegenerative diseases. A systematic review. Nutritional Neuroscience 24:10, pages 810-834.
Read now
Read now
Marc Gotkine, Denise Kviatcovsky & Eran Elinav. (2020) Amyotrophic lateral sclerosis and intestinal microbiota—toward establishing cause and effect. Gut Microbes 11:6, pages 1833-1841.
Read now
Read now
Shyuan T. Ngo, Ruben P.A. van Eijk, V. Chachay, Leonard H. van den Berg, Pamela A. McCombe, Robert D. Henderson & Frederik J. Steyn. (2019) Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:7-8, pages 497-505.
Read now
Read now
Ching-Piao Tsai, Chenyu Hu & Charles Tzu-Chi Lee. (2019) Finding diseases associated with amyotrophic lateral sclerosis: a total population-based case–control study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 82-89.
Read now
Read now
Éilis J. O’Reilly, Molin Wang, Hans-Olov Adami, Alvaro Alonso, Leslie Bernstein, Piet van den Brandt, Julie Buring, Sarah Daugherty, Dennis Deapen, D. Michal Freedman, Dallas R. English, Graham G. Giles, Niclas Håkansson, Tobias Kurth, Catherine Schairer, Elisabete Weiderpass, Alicja Wolk & Stephanie A. Smith-Warner. (2018) Prediagnostic body size and risk of amyotrophic lateral sclerosis death in 10 studies. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:5-6, pages 396-406.
Read now
Read now
Éilis J. O’Reilly, Kjetil Bjornevik, Michael A. Schwarzschild, Marjorie L. McCullough, Laurence N. Kolonel, Loic Le Marchand, Joann E. Manson & Alberto Ascherio. (2018) Pre-diagnostic plasma urate and the risk of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:3-4, pages 194-200.
Read now
Read now
ÉIlis J. O’Reilly, Dawei Liu, Donald R. Johns, Merit E. Cudkowicz, Sabrina Paganoni, Michael A. Schwarzschild, Melanie Leitner & Alberto Ascherio. (2017) Serum urate at trial entry and ALS progression in EMPOWER. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:1-2, pages 120-125.
Read now
Read now
Marianthi-Anna Kioumourtzoglou, Ryan M. Seals, Ole Gredal, Murray A. Mittleman, Johnni Hansen & Marc G. Weisskopf. (2016) Cardiovascular disease and diagnosis of amyotrophic lateral sclerosis: A population based study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:7-8, pages 548-554.
Read now
Read now
Gary G. Schwartz & Marilyn G. Klug. (2016) Motor neuron disease mortality rates in U.S. states are associated with well water use. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:7-8, pages 528-534.
Read now
Read now
Caroline Ingre, Per M Roos, Fredrik Piehl, Freya Kamel & Fang Fang. (2015) Risk factors for amyotrophic lateral sclerosis. Clinical Epidemiology 7, pages 181-193.
Read now
Read now
Articles from other publishers (114)
Ramona Meanti, Elena Bresciani, Laura Rizzi, Silvia Coco, Vanessa Zambelli, Anna Dimitroulas, Laura Molteni, Robert J. Omeljaniuk, Vittorio Locatelli & Antonio Torsello. (2023) Potential Applications for Growth Hormone Secretagogues Treatment of
Amyotrophic Lateral Sclerosis. Current Neuropharmacology 21:12, pages 2376-2394.
Crossref
Crossref
Jee Eun Oh, Jee Ah Oh, Mary Demopoulos, Karen M Clark & Matthew CL Phillips. (2023) Impact of the metabolic syndrome on prevalence and survival in motor neuron disease: a retrospective case series. Metabolic Brain Disease 38:8, pages 2583-2589.
Crossref
Crossref
Seok‐Jin Choi, Soon Ho Yoon, Jung‐Joon Sung & Jong Hyuk Lee. (2023)
Association Between Fat Depletion and Prognosis of Amyotrophic Lateral Sclerosis:
CT
‐Based Body Composition Analysis
. Annals of Neurology 94:6, pages 1116-1125.
Crossref
Crossref
Susana Pinto, Miguel Oliveira Santos, Marta Gromicho, Michael Swash & Mamede de Carvalho. (2023) Impact of diabetes mellitus on the respiratory function of amyotrophic lateral sclerosis patients. European Journal of Neurology.
Crossref
Crossref
Wen Cao, Zhi Cao, Yao Tian, Linjing Zhang, Wenjing Wang, Lu Tang, Chenjie Xu & Dongsheng Fan. (2023)
Neutrophils Are Associated with Higher Risk of Incident Amyotrophic Lateral Sclerosis in a
BMI
‐ and Age‐Dependent Manner
. Annals of Neurology 94:5, pages 942-954.
Crossref
Crossref
Stephanie L. Howe, Cory J. Holdom, Pamela A. McCombe, Robert D. Henderson, Jeffrey M. Zigman, Shyuan T. Ngo & Frederik J. Steyn. (2023) Associations of postprandial ghrelin, liver‐expressed antimicrobial peptide 2 and leptin levels with body composition, disease progression and survival in patients with amyotrophic lateral sclerosis. European Journal of Neurology.
Crossref
Crossref
Albert Ludolph, Luc Dupuis, Edward Kasarskis, Frederik Steyn, Shyuan Ngo & Christopher McDermott. (2023) Nutritional and metabolic factors in amyotrophic lateral sclerosis. Nature Reviews Neurology 19:9, pages 511-524.
Crossref
Crossref
M. Claudia Gonzalez Deniselle, Mariela Bettini, Rosa M. Garrido, Maria Meyer, Agustina Lara, Laura I. Garay, Sebastian Casas, Ernesto Fulgenzi, Myriam Nuñez, Marcelo F. Rugiero, Alejandro F. De Nicola & Gisella Gargiulo‐Monachelli. (2023) Exposure to endogenous and exogenous sex hormones and reproductive history influence prognosis in women with ALS. Muscle & Nerve.
Crossref
Crossref
Matei Bolborea, Pauline Vercruysse, Tselmen Daria, Johanna C. Reiners, Najwa Ouali Alami, Simon J. Guillot, Stéphane Dieterlé, Jérôme Sinniger, Jelena Scekic-Zahirovic, Amela Londo, Hippolyte Arcay, Marc-Antoine Goy, Claudia Nelson de Tapia, Dietmar R. Thal, Kazumoto Shibuya, Ryo Otani, Kimihito Arai, Satoshi Kuwabara, Albert C. Ludolph, Francesco Roselli, Deniz Yilmazer-Hanke & Luc Dupuis. (2023) Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis. Acta Neuropathologica 145:6, pages 773-791.
Crossref
Crossref
Nils Skajaa, Emil Bjerregaard Riahi, Szimonetta Komjáthiné Szépligeti, Erzsébet Horváth‐Puhó, Trine Toft Sørensen, Victor W. Henderson & Henrik Toft Sørensen. (2023) Type 2 diabetes, obesity, and risk of amyotrophic lateral sclerosis: A population‐based cohort study. Brain and Behavior 13:6.
Crossref
Crossref
Stephen A. Goutman, Jonathan Boss, Gayatri Iyer, Hani Habra, Masha G. Savelieff, Alla Karnovsky, Bhramar Mukherjee & Eva L. Feldman. (2022) Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles. Muscle & Nerve 67:3, pages 208-216.
Crossref
Crossref
Andrew T. Nelson & Davide Trotti. (2022) Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis. Neurotherapeutics 19:4, pages 1102-1118.
Crossref
Crossref
Gemma L. Sadler, Katherine N. Lewis, Vinod K. Narayana, David P. De Souza, Joel Mason, Catriona McLean, David G. Gonsalvez, Bradley J. Turner & Samantha K. Barton. (2022) Lipid Metabolism Is Dysregulated in the Motor Cortex White Matter in Amyotrophic Lateral Sclerosis. Metabolites 12:6, pages 554.
Crossref
Crossref
Robert David Henderson, Kasper Planeta Kepp & Andrew Eisen. (2022) ALS/FTD: Evolution, Aging, and Cellular Metabolic Exhaustion. Frontiers in Neurology 13.
Crossref
Crossref
Silvia Scaricamazza, Illari Salvatori, Susanna Amadio, Valentina Nesci, Alessio Torcinaro, Giacomo Giacovazzo, Aniello Primiano, Michela Gloriani, Niccolò Candelise, Luisa Pieroni, Jean‐Philippe Loeffler, Frederique Renè, Cyril Quessada, Tesfaye W. Tefera, Hao Wang, Frederik J. Steyn, Shyuan T. Ngo, Gabriella Dobrowolny, Elisa Lepore, Andrea Urbani, Antonio Musarò, Cinzia Volonté, Elisabetta Ferraro, Roberto Coccurello, Cristiana Valle & Alberto Ferri. (2022)
Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1
G93A
mice
. British Journal of Pharmacology 179:8, pages 1732-1752.
Crossref
Crossref
Kelby M. Killoy, Benjamin A. Harlan, Mariana Pehar & Marcelo R. Vargas. (2022) NR1D1 downregulation in astrocytes induces a phenotype that is detrimental to cocultured motor neurons. The FASEB Journal 36:4.
Crossref
Crossref
Jon Ondaro, Haizea Hernandez-Eguiazu, Maddi Garciandia-Arcelus, Raúl Loera-Valencia, Laura Rodriguez-Gómez, Andrés Jiménez-Zúñiga, Julen Goikolea, Patricia Rodriguez-Rodriguez, Javier Ruiz-Martinez, Fermín Moreno, Adolfo Lopez de Munain, Ian James Holt, Francisco Javier Gil-Bea & Gorka Gereñu. (2022) Defects of Nutrient Signaling and Autophagy in Neurodegeneration. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Shweta Goyal, Brashket Seth & Rajnish K. Chaturvedi. (2022) Polyphenols and Stem Cells for Neuroregeneration in Parkinson’s Disease and Amyotrophic Lateral Sclerosis. Current Pharmaceutical Design 28:10, pages 806-828.
Crossref
Crossref
Shan Ye, Yishan Luo, Pingping Jin, Yajun Wang, Nan Zhang, Gan Zhang, Lu Chen, Lin Shi & Dongsheng Fan. (2022) MRI Volumetric Analysis of the Thalamus and Hypothalamus in Amyotrophic Lateral Sclerosis. Frontiers in Aging Neuroscience 13.
Crossref
Crossref
Hoda S. Abdel Magid, Barbara Topol, Valerie McGuire, Jessica A. Hinman, Edward J. Kasarskis & Lorene M. Nelson. (2022) Cardiovascular Diseases, Medications, and ALS: A Population-Based Case-Control Study. Neuroepidemiology 56:6, pages 423-432.
Crossref
Crossref
Alexander G Thompson, Kevin Talbot & Martin R Turner. (2022) Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 93:1, pages 75-81.
Crossref
Crossref
Ryan Massopust, Devin Juros, Dillon Shapiro, Mikayla Lopes, Saptarsi M. Haldar, Thomas Taetzsch & Gregorio Valdez. (2022) KLF15 overexpression in myocytes fails to ameliorate ALS-related pathology or extend the lifespan of SOD1G93A mice. Neurobiology of Disease 162, pages 105583.
Crossref
Crossref
Tesfaye Wolde Tefera, Frederik J. Steyn, Shyuan T. Ngo & Karin Borges. (2021) CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?. Cell & Bioscience 11:1.
Crossref
Crossref
Angela RosenbohmRaphael Peter, Johannes Dorst, Jan Kassubek, Dietrich Rothenbacher, Gabriele Nagel, Albert C. Ludolph, Frank Andres, Guy Arnold, Hartmut Baier, Hansjoerg Baezner, James Beattie, Friedrich Behne, Dietmar Bengel, Axel Boertlein, Bracknies Vera, Burkhard Alber, Mathias Buttmann, Silke Dempewolf, Christian Dettmers, Wolfgang Freund, Thomas Gasser, Hans-Juergen Gold, Gerhard Hamann, Martin Hecht, Bernhard Heimbach, Birgit Herting, Roman Huber, Paul-Juergen Huelser, Karlheinz HuberHartmann, Eric Jüttler, Attila Kaspar, Rolf Kern, Hubert Kimmig, Klötzsch Christof, Anastasios Chatzikonstantinou, Thomas Klopstock, Andreas Kohler, Christoph Lichy, Alfred Lindner, Paul Lingor, Dorothee Lulé, Jens Metrikat, Oliver Meudt, Andreas Meyer, Andrea Naegele, Markus Naumann, Klaus-Dieter Neher, Oliver Neuhaus, Clemens Neusch, Ludwig Niehaus, Jan Raape, Peter Ratzka, Matthias Reinhard, Johann Rothmeier, Michael Sabolek, Martin Schabet, MDMario SchaeffVogelsang, Caroline Schell, Caroline Schell, Barbara Schweigert, Norbert Sommer, Mark Stroick, Mathis Synofzik, Hayrettin Tumani, Jens Volkmann, Markus Weiler, Wolfgang Wick, Christian Opherk, Cornelius Weiller, Daniel Zeller, Jessica Baumgärtner, Christoph Born, Martin Bürgy, Bernhard Connemann, Elmar Etzersdorfer, Hubertus Friederich, Maximilian Gahr, Alex Gogolkiewicz, Ralf Greber, Jochen Gebhardt, Heinz Grunze, Karsten Henkel, Walter Hewer, Andreas Raether, Andreas Joos, Matthias Köhler, Ralf Kozian, Christoph Laske, Alexandros Michaelides, Matthias Munk, Andreas Niestroj, Max Schmauss, Max Schmauss, Katrin SchoenebergerStroick, Kai-Uwe Schoerner, Stefan Spannhorst, Raimund Steber, Christine Thomas & Nenad Vasic. (2021) Life Course of Physical Activity and Risk and Prognosis of Amyotrophic Lateral Sclerosis in a German ALS Registry. Neurology 97:19.
Crossref
Crossref
Polina S. Goncharova, Tatiana K. Davydova, Tatiana E. Popova, Maxim A. Novitsky, Marina M. Petrova, Oksana A. Gavrilyuk, Mustafa Al-Zamil, Natalia G. Zhukova, Regina F. Nasyrova & Natalia A. Shnayder. (2021) Nutrient Effects on Motor Neurons and the Risk of Amyotrophic Lateral Sclerosis. Nutrients 13:11, pages 3804.
Crossref
Crossref
Jiangwei Sun, Tingting Huang, Justine W. Debelius & Fang Fang. (2021) Gut microbiome and amyotrophic lateral sclerosis: A systematic review of current evidence. Journal of Internal Medicine 290:4, pages 758-788.
Crossref
Crossref
Simon J. Guillot, Matei Bolborea & Luc Dupuis. (2021) Dysregulation of energy homeostasis in amyotrophic lateral sclerosis. Current Opinion in Neurology 34:5, pages 773-780.
Crossref
Crossref
Yuval Nash & Michal Sitty. (2021) Non-Motor Symptoms of Amyotrophic Lateral Sclerosis: A Multi-Faceted Disorder. Journal of Neuromuscular Diseases 8:4, pages 699-713.
Crossref
Crossref
Emanuele D’Amico, Giuseppe Grosso, Jeri W. Nieves, Aurora Zanghì, Pam Factor-Litvak & Hiroshi Mitsumoto. (2021) Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis. Nutrients 13:7, pages 2273.
Crossref
Crossref
Cyril Quessada, Alexandra Bouscary, Frédérique René, Cristiana Valle, Alberto Ferri, Shyuan T. Ngo & Jean-Philippe Loeffler. (2021) Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?. Cells 10:6, pages 1449.
Crossref
Crossref
Jose Enrique de la Rubia Ortí, Jose Luis Platero Armero, Claudia Emmanuela Sanchis-Sanchis, Sandra Sancho-Castillo, Alejandro Salazar, Jordi Caplliure-Llopis, Esther Navarro-Illana, Carlos Barrios, Jesús Escribá-Alepuz & María Benlloch. (2021) Muscle Function Differences between Patients with Bulbar and Spinal Onset Amyotrophic Lateral Sclerosis. Does It Depend on Peripheral Glucose?. Journal of Clinical Medicine 10:8, pages 1582.
Crossref
Crossref
Pavlína Hemerková & Martin Vališ. (2021) Role of Oxidative Stress in the Pathogenesis of Amyotrophic Lateral Sclerosis: Antioxidant Metalloenzymes and Therapeutic Strategies. Biomolecules 11:3, pages 437.
Crossref
Crossref
Kelby M. Killoy, Mariana Pehar, Benjamin A. Harlan & Marcelo R. Vargas. (2021) Altered expression of clock and clock‐controlled genes in a hSOD1‐linked amyotrophic lateral sclerosis mouse model. The FASEB Journal 35:2.
Crossref
Crossref
Mariana Pereira, Marta Gromicho, Ana Henriques, Ana Catarina Pronto-Laborinho, Julian Grosskreutz, Magdalena Kuźma-Kozakiewicz, Susanne Petri, Hilmi Uysal, Michael Swash & Mamede de Carvalho. (2021) Cardiovascular comorbidities in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 421, pages 117292.
Crossref
Crossref
Rebekah M. Ahmed, Frederik Steyn & Luc Dupuis. 2021. The Human Hypothalamus - Middle and Posterior Region. The Human Hypothalamus - Middle and Posterior Region
327
338
.
Roger E. Kelley. 2021. The Human Hypothalamus. The Human Hypothalamus
479
495
.
Gregory T. Carter, Ryan J. McLaughlin, Carrie Cuttler, Garrett J. Sauber, Douglas L. Weeks, Cecilia J. Hillard & Michael D. Weiss. (2020) Endocannabinoids and related lipids in serum from patients with amyotrophic lateral sclerosis. Muscle & Nerve 63:1, pages 120-126.
Crossref
Crossref
Lishun Xiao, Zhongshang Yuan, Siyi Jin, Ting Wang, Shuiping Huang & Ping Zeng. (2020) Multiple-Tissue Integrative Transcriptome-Wide Association Studies Discovered New Genes Associated With Amyotrophic Lateral Sclerosis. Frontiers in Genetics 11.
Crossref
Crossref
Vittorio Emanuele Bianchi, Laura Rizzi, Elena Bresciani, Robert J Omeljaniuk & Antonio Torsello. (2020) Androgen Therapy in Neurodegenerative Diseases. Journal of the Endocrine Society 4:11.
Crossref
Crossref
Francesco Gentile, Pietro Emiliano Doneddu, Nilo Riva, Eduardo Nobile-Orazio & Angelo Quattrini. (2020) Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration. International Journal of Molecular Sciences 21:20, pages 7471.
Crossref
Crossref
Colin Quinn & Lauren Elman. (2020) Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases. CONTINUUM: Lifelong Learning in Neurology 26:5, pages 1323-1347.
Crossref
Crossref
J. Schumacher, R. S. Peter, G. Nagel, D. Rothenbacher, A. Rosenbohm, A. C. Ludolph & J. Dorst. (2020) Statins, diabetes mellitus and prognosis of amyotrophic lateral sclerosis: data from 501 patients of a population‐based registry in southwest Germany. European Journal of Neurology 27:8, pages 1405-1414.
Crossref
Crossref
Kristin Diekmann, Magdalena Kuzma-Kozakiewicz, Maria Piotrkiewicz, Marta Gromicho, Julian Grosskreutz, Peter M. Andersen, Mamede de Carvalho, Hilmi Uysal, Alma Osmanovic, Olivia Schreiber-Katz, Susanne Petri & Sonja Körner. (2020) Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group. Journal of Neurology 267:7, pages 2130-2141.
Crossref
Crossref
Beata Chełstowska & Magdalena Kuźma-Kozakiewicz. (2020) Biochemical parameters in determination of nutritional status in amyotrophic lateral sclerosis. Neurological Sciences 41:5, pages 1115-1124.
Crossref
Crossref
Hari Krishna Raju Sagiraju, Sasa Živković, Anne C VanCott, Huned Patwa, David Gimeno Ruiz de Porras, Megan E Amuan & Mary Jo V Pugh. (2020) Amyotrophic Lateral Sclerosis Among Veterans Deployed in Support of Post-9/11 U.S. Conflicts. Military Medicine 185:3-4, pages e501-e509.
Crossref
Crossref
Linjing Zhang, Lu Tang, Tao Huang & Dongsheng Fan. (2020) Life Course Adiposity and Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study. Annals of Neurology 87:3, pages 434-441.
Crossref
Crossref
Éilis J. O'ReillyKjetil BjornevikJeremy D. FurtadoLaurence N. KolonelLoic Le MarchandMarjorie L. McCulloughVictoria L. StevensAladdin H. ShadyabLinda SnetselaarJoAnn E. MansonAlberto Ascherio. (2020) Prediagnostic plasma polyunsaturated fatty acids and the risk of amyotrophic lateral sclerosis. Neurology 94:8.
Crossref
Crossref
Valentina Gallo. (2020) Amyotrophic lateral sclerosis on the scale. Neurology 94:8, pages 339-340.
Crossref
Crossref
Albert C. Ludolph, Johannes Dorst, Jens Dreyhaupt, Jochen H. Weishaupt, Jan Kassubek, Ulrike Weiland, Thomas Meyer, Susanne Petri, Andreas Hermann, Alexander Emmer, Julian Grosskreutz, Torsten Grehl, Daniel Zeller, Matthias Boentert, Bertold Schrank, Johannes Prudlo, Andrea S. Winkler, Stanislav Gorbulev, Francesco Roselli, Joachim Schuster & Luc Dupuis. (2020) Effect of High‐Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis. Annals of Neurology 87:2, pages 206-216.
Crossref
Crossref
Mara-Luciana Floare & Scott P. Allen. (2020) Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis. Neuroscience Insights 15, pages 263310552095730.
Crossref
Crossref
Ava Nasrolahi, Javad Mahmoudi, Ali Noori-Zadeh, Karimeh Haghani, Salar Bakhtiyari & Shahram Darabi. (2019) Shared Pathological Mechanisms Between Diabetes Mellitus and Neurodegenerative Diseases. Current Pharmacology Reports 5:4, pages 219-231.
Crossref
Crossref
Ola Nakken, Haakon E. MeyerHein StigumTrygve Holmøy. (2019) High BMI is associated with low ALS risk. Neurology 93:5.
Crossref
Crossref
Trine Toft Sørensen, Erzsébet Horváth-Puhó, Mette Nørgaard, Vera Ehrenstein & Victor W Henderson. (2019) Risk of amyotrophic lateral sclerosis and other motor neuron disease among men with benign prostatic hyperplasia: a population-based cohort study. BMJ Open 9:7, pages e030015.
Crossref
Crossref
Natalia Nowicka, Jakub Juranek, Judyta K. Juranek & Joanna Wojtkiewicz. (2019) Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 20:11, pages 2616.
Crossref
Crossref
Ping Zeng, Xinghao Yu & Haibo Xu. (2019) Association Between Premorbid Body Mass Index and Amyotrophic Lateral Sclerosis: Causal Inference Through Genetic Approaches. Frontiers in Neurology 10.
Crossref
Crossref
Vy T. Nguyen, Ross D. Zafonte, Jarvis T. Chen, Kalé Z. Kponee-Shovein, Sabrina Paganoni, Alvaro Pascual-Leone, Frank E. Speizer, Aaron L. Baggish, Herman A. TaylorJrJr, Lee M. Nadler, Theodore K. Courtney, Ann Connor & Marc G. Weisskopf. (2019) Mortality Among Professional American-Style Football Players and Professional American Baseball Players. JAMA Network Open 2:5, pages e194223.
Crossref
Crossref
Kjetil Bjornevik, Zhongli ZhangÉilis J. O'ReillyJames D. BerryClary B. Clish, Amy DeikSarah JeanfavreIkuko KatoRachel S. KellyLaurence N. KolonelLiming LiangLoic Le MarchandMarjorie L. McCulloughSabrina PaganoniKerry A. PierceMichael A. SchwarzschildAladdin H. ShadyabJean Wactawski-WendeDong D. WangYing WangJoAnn E. MansonAlberto Ascherio. (2019) Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis. Neurology 92:18.
Crossref
Crossref
Siobhan E. Kirk, Timothy J. Tracey, Frederik J. Steyn & Shyuan T. Ngo. (2019) Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis. Frontiers in Neurology 10.
Crossref
Crossref
A.-S. Biesalski, J. Becktepe, T. Bartsch & C. Franke. 2019. Neurologische Pathophysiologie. Neurologische Pathophysiologie
117
164
.
Ali Jawaid, Romesa Khan, Magdalini Polymenidou & Paul E. Schulz. (2018) Disease-modifying effects of metabolic perturbations in ALS/FTLD. Molecular Neurodegeneration 13:1.
Crossref
Crossref
Efthimios DardiotisVasileios SiokasMaria SokratousZisis TsourisAthina-Maria AloizouDesponia FlorouMetaxia DastamaniAlexios-Fotios A. MentisAlexandros G. Brotis. (2018) Body mass index and survival from amyotrophic lateral sclerosis. Neurology Clinical Practice 8:5, pages 437-444.
Crossref
Crossref
Gabriella Dobrowolny, Elisa Lepore, Martina Martini, Laura Barberi, Abigail Nunn, Bianca Maria Scicchitano & Antonio Musarò. (2018) Metabolic Changes Associated With Muscle Expression of SOD1G93A. Frontiers in Physiology 9.
Crossref
Crossref
Tijs Vandoorne, Katrien De Bock & Ludo Van Den Bosch. (2018) Energy metabolism in ALS: an underappreciated opportunity?. Acta Neuropathologica 135:4, pages 489-509.
Crossref
Crossref
Maria Åberg, Jenny Nyberg, Josefina Robertson, Georg Kuhn, Linus Schiöler, Hans Nissbrandt, Margda Waern & Kjell Torén. (2017) Risk factors in Swedish young men for amyotrophic lateral sclerosis in adulthood. Journal of Neurology 265:3, pages 460-470.
Crossref
Crossref
Pauline Vercruysse, Didier Vieau, David Blum, Åsa Petersén & Luc Dupuis. (2018) Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
F. D'Ovidio, A. d'Errico, P. Carnà, A. Calvo, G. Costa & A. Chiò. (2018) The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis. European Journal of Neurology 25:1, pages 164-170.
Crossref
Crossref
A. Weerasekera, D.M. Sima, T. Dresselaers, S. Van Huffel, P. Van Damme & U. Himmelreich. (2018) Non-invasive assessment of disease progression and neuroprotective effects of dietary coconut oil supplementation in the ALS SOD1G93A mouse model: A 1H-magnetic resonance spectroscopic study. NeuroImage: Clinical 20, pages 1092-1105.
Crossref
Crossref
Luc Dupuis, Åsa Petersen & Patrick Weydt. 2018. Thermoregulation: From Basic Neuroscience to Clinical Neurology, Part II. Thermoregulation: From Basic Neuroscience to Clinical Neurology, Part II
749
760
.
Qian-Qian Wei, Yongping Chen, Bei Cao, Ru Wei Ou, Lingyu Zhang, Yanbing Hou, Xiang Gao & Huifang Shang. (2017) Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival. Molecular Neurodegeneration 12:1.
Crossref
Crossref
Martin Gorges, Pauline Vercruysse, Hans-Peter Müller, Hans-Jürgen Huppertz, Angela Rosenbohm, Gabriele Nagel, Patrick Weydt, Åsa Petersén, Albert C Ludolph, Jan Kassubek & Luc Dupuis. (2017) Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 88:12, pages 1033-1041.
Crossref
Crossref
Shachee Doshi, Preetika Gupta & Robert G. Kalb. (2017) Genetic induction of hypometabolism by ablation of MC4R does not suppress ALS-like phenotypes in the G93A mutant SOD1 mouse model. Scientific Reports 7:1.
Crossref
Crossref
Raphael Simon Peter, Angela Rosenbohm, Luc Dupuis, Torben Brehme, Jan Kassubek, Dietrich Rothenbacher, Gabriele Nagel & Albert Christian Ludolph. (2017) Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia. European Journal of Epidemiology 32:10, pages 901-908.
Crossref
Crossref
Hannah C. Timmins, Wilfred Saw, Benjamin C. Cheah, Cindy S.Y. Lin, Steve Vucic, Rebekah M. Ahmed, Matthew C. Kiernan & Susanna B. Park. (2017) Cardiometabolic health and risk of amyotrophic lateral sclerosis. Muscle & Nerve 56:4, pages 721-725.
Crossref
Crossref
Anne E Visser, Meinie Seelen, Alexander Hulsbergen, Joris de Graaf, Anneke J van der Kooi, Joost Raaphorst, Jan H Veldink & Leonard H van den Berg. (2017) Exploring the fitness hypothesis in ALS: a population-based case-control study of parental cause of death and lifespan. Journal of Neurology, Neurosurgery & Psychiatry 88:7, pages 550-556.
Crossref
Crossref
Ming-Dong Wang, Julian Little, James Gomes, Neil R. Cashman & Daniel Krewski. (2017) Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. NeuroToxicology 61, pages 101-130.
Crossref
Crossref
Gabriele Nagel, Raphael S. Peter, Angela Rosenbohm, Wolfgang Koenig, Luc Dupuis, Dietrich Rothenbacher & Albert C. Ludolph. (2017) Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany. Scientific Reports 7:1.
Crossref
Crossref
M.-H. Soriani & C. Desnuelle. (2017) Care management in amyotrophic lateral sclerosis. Revue Neurologique 173:5, pages 288-299.
Crossref
Crossref
Daniela Mariosa, John D. Beard, David M. Umbach, Rino Bellocco, Jean Keller, Tracy L. Peters, Kelli D. Allen, Weimin Ye, Dale P. Sandler, Silke Schmidt, Fang Fang & Freya Kamel. (2017) Body Mass Index and Amyotrophic Lateral Sclerosis: A Study of US Military Veterans. American Journal of Epidemiology 185:5, pages 362-371.
Crossref
Crossref
Tesfaye W. Tefera & Karin Borges. (2017) Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments. Frontiers in Neuroscience 10.
Crossref
Crossref
Alberto Ferri & Roberto Coccurello. (2017) What is “Hyper” in the ALS Hypermetabolism?. Mediators of Inflammation 2017, pages 1-11.
Crossref
Crossref
M. Swash & M. de Carvalho. (2016) Risk factors for onset of amyotrophic lateral sclerosis. European Journal of Neurology 24:1, pages 9-10.
Crossref
Crossref
E. Longinetti, D. Mariosa, H. Larsson, C. Almqvist, P. Lichtenstein, W. Ye & F. Fang. (2016) Physical and cognitive fitness in young adulthood and risk of amyotrophic lateral sclerosis at an early age. European Journal of Neurology 24:1, pages 137-142.
Crossref
Crossref
Jihye Lee, Heejoon Baek, Seung Hyun Kim & Yongsoon Park. (2017) Association between estimated total daily energy expenditure and stage of amyotrophic lateral sclerosis. Nutrition 33, pages 181-186.
Crossref
Crossref
Liliana Letra & Isabel Santana. 2017. Obesity and Brain Function. Obesity and Brain Function
151
161
.
Hristelina Ilieva & Nicholas J. Maragakis. 2017. Neurodegenerative Diseases. Neurodegenerative Diseases
191
210
.
Theocharis Stavroulakis & Christopher J. McDermott. 2017. Nutrition in Neurologic Disorders. Nutrition in Neurologic Disorders
91
104
.
Vincent Picher-Martel, Paul N. Valdmanis, Peter V. Gould, Jean-Pierre Julien & Nicolas Dupré. (2016) From animal models to human disease: a genetic approach for personalized medicine in ALS. Acta Neuropathologica Communications 4:1.
Crossref
Crossref
Claudinéa. S. Almeida, Patricia Stanich, Cristina C. S. Salvioni & Solange Diccini. (2016) Assessment and nutrition education in patients with amyotrophic lateral sclerosis. Arquivos de Neuro-Psiquiatria 74:11, pages 902-908.
Crossref
Crossref
Kaitlin A. HaganKassandra L. MungerAlberto AscherioFrancine Grodstein. (2016) Epidemiology of Major Neurodegenerative Diseases in Women: Contribution of the Nurses’ Health Study. American Journal of Public Health 106:9, pages 1650-1655.
Crossref
Crossref
Mónica Zufiría, Francisco Javier Gil-Bea, Roberto Fernández-Torrón, Juan José Poza, Jose Luis Muñoz-Blanco, Ricard Rojas-García, Javier Riancho & Adolfo López de Munain. (2016) ALS: A bucket of genes, environment, metabolism and unknown ingredients. Progress in Neurobiology 142, pages 104-129.
Crossref
Crossref
Pauline Vercruysse, Jérôme Sinniger, Hajer El Oussini, Jelena Scekic-Zahirovic, Stéphane Dieterlé, Reinhard Dengler, Thomas Meyer, Stephan Zierz, Jan Kassubek, Wilhelm Fischer, Jens Dreyhaupt, Torsten Grehl, Andreas Hermann, Julian Grosskreutz, Anke Witting, Ludo Van Den Bosch, Odile Spreux-Varoquaux, Albert C. Ludolph & Luc Dupuis. (2016) Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis. Brain 139:4, pages 1106-1122.
Crossref
Crossref
Sabrina K. Hollinger, Ike S. Okosun & Cassie S. Mitchell. (2016) Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?. Frontiers in Neurology 7.
Crossref
Crossref
Rebekah M Ahmed, Muireann Irish, Olivier Piguet, Glenda M Halliday, Lars M Ittner, Sadaf Farooqi, John R Hodges & Matthew C Kiernan. (2016) Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism. The Lancet Neurology 15:3, pages 332-342.
Crossref
Crossref
Nirma D. Perera & Bradley J. Turner. (2015) AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis. Neurochemical Research 41:3, pages 544-553.
Crossref
Crossref
Alberto Ascherio & Eilis Joan O’Reilly. (2016) New insights on physical activity and amyotrophic lateral sclerosis. European Journal of Epidemiology 31:3, pages 213-215.
Crossref
Crossref
Valentina Gallo, Nicola Vanacore, H. Bas Bueno-de-Mesquita, Roel Vermeulen, Carol Brayne, Neil Pearce, Petra A. Wark, Heather A. Ward, Pietro Ferrari, Mazda Jenab, Peter M. Andersen, Patrik Wennberg, Nicholas Wareham, Verena Katzke, Rudolf Kaaks, Elisabete Weiderpass, Petra H. Peeters, Amalia Mattiello, Valeria Pala, Aurelio Barricante, Maria-Dolores Chirlaque, Noémie Travier, Ruth C. Travis, Maria-Jose Sanchez, Hélène Pessah-Rasmussen, Jesper Petersson, Anne Tjønneland, Rosario Tumino, Jose Ramon Quiros, Antonia Trichopoulou, Andreas Kyrozis, Despoina Oikonomidou, Giovanna Masala, Carlotta Sacerdote, Larraitz Arriola, Heiner Boeing, Matthaeus Vigl, Francoise Claver-Chapelon, Lefkos Middleton, Elio Riboli & Paolo Vineis. (2016) Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study. European Journal of Epidemiology 31:3, pages 255-266.
Crossref
Crossref
Ryan M. Seals, Johnni Hansen, Ole Gredal & Marc G. Weisskopf. (2016) Physical Trauma and Amyotrophic Lateral Sclerosis: A Population-Based Study Using Danish National Registries. American Journal of Epidemiology 183:4, pages 294-301.
Crossref
Crossref
D. Mariosa, F. Kamel, R. Bellocco, W. Ye & F. Fang. (2015) Association between diabetes and amyotrophic lateral sclerosis in Sweden. European Journal of Neurology 22:11, pages 1436-1442.
Crossref
Crossref
Sabrina Paganoni, Theodore Hyman, Amy Shui, Peggy Allred, Matthew Harms, Jingxia Liu, Nicholas Maragakis, David Schoenfeld, Hong Yu, Nazem Atassi, Merit Cudkowicz & Timothy M. Miller. (2015) Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis. Muscle & Nerve 52:3, pages 339-343.
Crossref
Crossref
Johannes Dorst, Luc Dupuis, Susanne Petri, Katja Kollewe, Susanne Abdulla, Joachim Wolf, Markus Weber, David Czell, Christian Burkhardt, Frank Hanisch, Stefan Vielhaber, Thomas Meyer, Gabriele Frisch, Dagmar Kettemann, Torsten Grehl, Bertold Schrank & Albert C. Ludolph. (2015) Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study. Journal of Neurology 262:4, pages 849-858.
Crossref
Crossref
Vincent Roubeau, Hélène Blasco, François Maillot, Philippe Corcia & Julien Praline. (2015) Nutritional assessment of amyotrophic lateral sclerosis in routine practice: Value of weighing and bioelectrical impedance analysis. Muscle & Nerve 51:4, pages 479-484.
Crossref
Crossref
S.T. Ngo & F.J. Steyn. (2015) The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis. Cell Regeneration 4:1, pages 4:5.
Crossref
Crossref
Cassie S. Mitchell, Sabrina K. Hollinger, Shivani D. Goswami, Meraida A. Polak, Robert H. Lee & Jonathan D. Glass. (2015) Antecedent Disease Is Less Prevalent in Amyotrophic Lateral Sclerosis. Neurodegenerative Diseases 15:2, pages 109-113.
Crossref
Crossref
Takamura Nagasaka & Yoshihisa Takiyama. 2015. Neurodegenerative Disorders as Systemic Diseases. Neurodegenerative Disorders as Systemic Diseases
237
275
.
Meinie Seelen, Perry T. C. van Doormaal, Anne E. Visser, Mark H. B. Huisman, Margot H. J. Roozekrans, Sonja W. de Jong, Anneke J. van der Kooi, Marianne de Visser, Nicol C. Voermans, Jan H. Veldink & Leonard H. van den Berg. (2014) Prior medical conditions and the risk of amyotrophic lateral sclerosis. Journal of Neurology 261:10, pages 1949-1956.
Crossref
Crossref
J. F. Ludvigsson, D. Mariosa, B. Lebwohl & F. Fang. (2014) No association between biopsy-verified celiac disease and subsequent amyotrophic lateral sclerosis - a population-based cohort study. European Journal of Neurology 21:7, pages 976-982.
Crossref
Crossref
Anne-Marie Wills, Jane Hubbard, Eric A Macklin, Jonathan Glass, Rup Tandan, Ericka P Simpson, Benjamin Brooks, Deborah Gelinas, Hiroshi Mitsumoto, Tahseen Mozaffar, Gregory P Hanes, Shafeeq S Ladha, Terry Heiman-Patterson, Jonathan Katz, Jau-Shin Lou, Katy Mahoney, Daniela Grasso, Robert Lawson, Hong Yu & Merit Cudkowicz. (2014) Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. The Lancet 383:9934, pages 2065-2072.
Crossref
Crossref
S.T. Ngo, F.J. Steyn & P.A. McCombe. (2014) Body mass index and dietary intervention: Implications for prognosis of amyotrophic lateral sclerosis. Journal of the Neurological Sciences 340:1-2, pages 5-12.
Crossref
Crossref
Ali Jawaid, Sabrina Paganoni, Cecile Hauser & Paul E. Schulz. (2014) Trials of Antidiabetic Drugs in Amyotrophic Lateral Sclerosis: Proceed with Caution?. Neurodegenerative Diseases 13:4, pages 205-208.
Crossref
Crossref
Roger Pamphlett & Anna Rikard-Bell. (2013) Different Occupations Associated with Amyotrophic Lateral Sclerosis: Is Diesel Exhaust the Link?. PLoS ONE 8:11, pages e80993.
Crossref
Crossref
Ammar Al-Chalabi & Orla Hardiman. (2013) The epidemiology of ALS: a conspiracy of genes, environment and time. Nature Reviews Neurology 9:11, pages 617-628.
Crossref
Crossref
E. Fondell, K. C. Fitzgerald, G. J. Falcone, E. J. O'Reilly & A. Ascherio. (2013) Early-Onset Alopecia and Amyotrophic Lateral Sclerosis: A Cohort Study. American Journal of Epidemiology 178:7, pages 1146-1149.
Crossref
Crossref
Johannes Dorst, Patrick Weydt & Albert Christian Ludolph. (2013) Ernährung und Metabolismus wichtig für die Prognose. NeuroTransmitter 24:10, pages 28-34.
Crossref
Crossref
Sabrina Paganoni & Anne-Marie Wills. (2013) High-Fat and Ketogenic Diets in Amyotrophic Lateral Sclerosis. Journal of Child Neurology 28:8, pages 989-992.
Crossref
Crossref